lenalidomide,dexamethasone,carfilzomib
amgen
['atlas']
results from #ash22- interim analysis of the atlas-ole study reveal that fitusiran prophylaxis treatment led to improved joint health, joint mobility and decreased bleeds. more promising data! what are you most excited to see as the study progresses? 